Drug
Resamirigene Bilparvovec
Resamirigene Bilparvovec: highest development phase Phase 2/3, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| Resamirigene bilparvovec NCT03199469 | Phase 2/3 | X-Linked Myotubular Myopathy |
Latest
No recent events.
Follow Resamirigene Bilparvovec on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.